FDA approves Eli Lilly’s injectable diabetes drug

Please subscribe to IBJ to decode this article.

muoist .s e tolUlndegd e i rmii nda s dr Faion.a f en dumoaitaaorp.v b ncc tCranretmgoto dse .esbohojwe rlths floAmylDdh rt a Sewfeho mdstaTd ihLniu e pa Efio

rsiend T gautyn rLtaiee pe nf tdee b elorcer ro1,i slcistcl shlc hs,ris crt usasysse ctaanofy areld golfctl e mhjt6 gtas ensmh naefose gel bi una u tn peiptoe PAaa nen sta 2.lliTale oayrutGwa ea ori adn h Tanuehnuel.mraordnhkonia mttT ini h,we ipcvw2 gtdcx camrhi ee iddrocm,ptopithohw esrria cywtcesoie-si icf

.e ;opi ghe seefseaooleocnwcradef3 y licfurml dtrery.eott hunt e.9cedlocnr#yhwp sceeae3 np nabtn e Trcesh#Lldl2htspsnrSoip o ethn g y marht onip&oiu 9utnruo eeur dhfa l olas .oiHls da9 snps & u p r noo ceusutc isre d inteoseoDimfrddct;eiea cuogsisstHl tteU,0eeso urnusah lb ri dai s

me nneeiie ec unwthinfelen tn bicldgoo e slfp.w ccbaipof f nctiutniC urtst,dkostlithsaaraiaLerh-sta nkhpcaek ipi ttmprilei trlc ici absbftsivu tsxrrnnaior y eeec egillToai dple a ieao easI etyynodg monreolstga r n plr guhe ne

.aleunnoo eda nitm l u$ o lsrunmly n1n0reha dl tevil l tubasrge igna tbtl phn $v l0 sndisuyni .ucy 7 3icAiao i e clre

se p er doie2diooogaau svd.ts ohuise li noe adietlFnu3tnn ruubrathya4unit t hrhavpcTm ten-d upt te ha p e xt Tm sdaesomge,rah c oiwcn sardhnina anl so is os tn tolpaa w udi Dg eost3s bt mr, ofmtmbs .riewmotsdA nsryneraibihiTde eleddyi ocnss d c

eaasu9aa#wpy& stTc ooilgh&g g;n tuuae t ; t ru.2l rdT1uilt 8st ec cdghy tyegfb d etciw;usn tsbsl riihe wahdrdr c t eigmnit2 hc y2er rh ee3 s#hthn oa hrhneer eoitbtr eheo h,aiegwxahwsyh8 <er 1 a #hdid rt2iu t os e

bu& urdit9dotcansls3rDeyrstgaLocao Alrw ee sae rsltuol t eetcstubnhsiutsoh iFpc r#iepd.lqt -l;ol r ulo yna kdiade ntrhdmssifnste i e t,euacv.c iaetrryepunydoiil eo ib t g orwe h fr sfghleuhdioirdqo sTe soa u sohsttcrulL w a ooei